Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
暂无分享,去创建一个
E. Estey | M. Konopleva | M. Andreeff | I. Samudio | Z. Zeng | M. Levis | Xiaoyang Ling | J. Rubin | S. Konoplev | Yue-xi Shi | Rui-yu Wang | O. Frolova | R. Negrin